BRTX vs K · rev $401.0K vs P/E 23, $29.03B cap
BioRestorative Therapies Inc (BRTX) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Kellanova (K) is a packaged foods company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
K does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the BRTX and K stock pages for the full models.
Not investment advice.